Belgium· BE-AMP-SAM339911-00
Mepact 4 mg
A mifamurtid product containing mifamurtide, registered in Belgium by Esteve Pharmaceuticals. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Mifamurtid is registered in 8 of 19 countries.
Countries holding a registration under ATC L03AX15 (mifamurtid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Mifamurtid · ATC L03AX15
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mifamurtide
- Manufacturer
- Esteve Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L03AX15
- ATC class
- Mifamurtid
- Defined daily dose
- 0.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mifamurtid in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMepact 4mg powder for concentrate for dispersion for infusion vialsTakeda UK Ltd
- FinlandMEPACTEsteve Pharmaceuticals, S.A
- IrelandMepact 4 mg Powder for concentrate for dispersion for infusionEsteve Pharmaceuticals S.A.
- PolandMepactEsteve Pharmaceuticals, S.A.
- SwedenMEPACT 4 mg Pulver till koncentrat till infusionsvätska, dispersionEsteve Pharmaceuticals S.A.
- SpainMEPACT 4 mg POLVO PARA SUSPENSION PARA PERFUSIONEsteve Pharmaceuticals S.A.
- IcelandMepactEsteve Pharmaceuticals S.A.
- NetherlandsMepact, poeder voor suspensie voor intraveneuze infusie, 4 mgEsteve Pharmaceuticals S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mepact
- Liechtenstein · Mepact
- Norway · Mepact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4767911-d456-48fa-a76d-6958a7cb6e6c GET /v1/drugs/f4767911-d456-48fa-a76d-6958a7cb6e6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for dispersion for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Mepact 4 mg",
"name_fr": "Mepact 4 mg",
"name_nl": "Mepact 4 mg",
"amp_code": "SAM339911-00",
"strengths": [
"4.0000",
"4.0000"
],
"pack_count": 1,
"substances": [
"Mifamurtide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Mifamurtide",
"authorisation_numbers": [
"EU/1/08/502/001"
]
}See everything about mifamurtid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.